Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tribendimidine dose-ranging trial for hookworm infection in children
ISRCTN81391471Phase 2Completed
- Sponsor
- Swiss Tropical and Public Health Institute
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of tribendimidine in hookworm infection (4 arms), sponsored by Swiss Tropical and Public Health Institute. Primary endpoint: Cure rate against hookworm infection. Started May 2017; status: completed.
02
Drugs
tribendimidine
03
Conditions
hookworm infection
Beyond the preview
Go deeper on ISRCTN81391471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN81391471.